Marken v. Teva Pharmaceuticals USA, Inc., et al.,
| Kristy Marken |
| Teva Women's Health, LLC. Individually and as Successor in interest to Teva Women's Health, Inc. doing business as Teva Women's Health, Inc., Teva Pharmaceuticals USA Inc., The Cooper Companies, Inc., Teva Women's Health Inc., Coopersurgical, Inc., Duramed Pharmaceuticals, Inc. A Division of Barr Pharmaceuticals, Inc. doing business as Teva Women's Health, Inc., Teva Women's Health, LLC., Teva Pharmaceuticals USA, Inc., Teva Women and Teva Women's Health, Inc. |
| 3:2020cv00092 |
| November 13, 2020 |
| US District Court for the Southern District of Iowa |
| Helen C Adams |
| John A Jarvey |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 8, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 27 Certified Conditional Transfer Order (CTO-1) by clerk's Office, Northern District of Georgia. (kjw) |
| ***Civil Case Terminated. Case electronically transferred to the Northern District of Georgia. (kjw) |
| Filing 26 Certified Conditional Transfer Order MDL No. 2974 for the Northern District of Georgia. (don) |
| Filing 25 TEXT MINUTE ORDER - TO INVOLVED CLERKS - Conditional Transfer Order (CTO-2974) Finalized on 12/19/20. Please see pleading (3 in FLM/3:20-cv-01284, 3 in GAM/3:20-cv-00128, 11 in HI/1:20-cv-00443, 11 in HI/1:20-cv-00444, 3 in IAS/3:20-cv-00092, 22 in ID/1:20-cv-00477, 3 in ILS/3:20-cv-01316, 4 in INS/1:20-cv-02628, 4 in KS/2:20-cv-02582, 3 in MA/1:20-cv-12051, 3 in MD/1:20-cv-03352, 75 in MDL No. 2974, 27 in MN/0:20-cv-02080, 27 in MN/0:20-cv-02081, 4 in MN/0:20-cv-02164, 4 in MN/0:20-cv-02286, 22 in MOW/4:20-cv-00796, 3 in MSN/3:20-cv-00302, 3 in NCE/7:20-cv-00217, 22 in NYE/1:20-cv-04835, 9 in NYS/1:20-cv-07979, 3 in PAE/2:20-cv-04768, 3 in PAE/2:20-cv-05063, 6 in PAE/2:20-cv-05249, 14 in TXE/4:20-cv-00761, 3 in TXN/3:20-cv-03415, 9 in TXW/1:20-cv-00989, 14 in TXW/1:20-cv-01020). As stipulated in Rule 7.1(c) of the Rules of Procedure of the Judicial Panel on Multidistrict Litigation, transmittal of the order has been stayed 7 days to give any party an opportunity to oppose the transfer. The 7-day period has now elapsed, no opposition was received, and the order is directed to the Clerk of the United States District Court for the N.D. Georgia for filing. The Panel governing statute, 28 U.S.C. 1407, requires that the transferee clerk transmit a certified copy of the Panel order to transfer to the clerk of the district court from which the action is being transferred.Signed by Clerk of the Panel John W. Nichols on 12/29/2020. (don) |
| Filing 24 RESPONSE to Motion re #21 MOTION to Stay PROCEEDINGS PENDING A DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT LITIGATION filed by CooperSurgical, Inc., Teva Pharmaceuticals USA, Inc., Teva Women's Health, Inc., Teva Women's Health, LLC.(Individually and as successor in interest to Teva Women's Health, Inc. ), The Cooper Companies, Inc.. Replies due by 12/29/2020. (Attachments: #1 Exhibit, #2 Exhibit)(Stefani, Richard) |
| Filing 23 TEXT ORDER RESETTING SCHEDULING CONFERENCE. The Telephonic Scheduling Conference set for 12/28/2020 is reset to 2/4/2021 at 10:00 AM before Chief Magistrate Judge Helen C. Adams. Counsel should call 1-877-336-1829 and enter access code 1176783 at the prompt to be joined with the call. The parties shall file a proposed scheduling order and discovery plan as provided under L.R. 16 by 1/28/2021. Signed by Chief Magistrate Judge Helen C. Adams on 12/11/2020. (bam) |
| Filing 22 ***Notice - Certificate of Conference - MDL*** CERTIFICATE by Kristy Marken. (Conlin, Roxanne) Modified on 12/11/2020 Corrected event and linked to motion #21 (slg). |
| Filing 21 MOTION to Stay PROCEEDINGS PENDING A DECISION BY THE JUDICIAL PANEL ON MULTIDISTRICT LITIGATION by Kristy Marken.Motions referred to Helen C. Adams. Responses due by 12/24/2020. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Text of Proposed Order Proposed Order for Motion to Stay)(Conlin, Roxanne) |
| Filing 20 NOTICE of Appearance by Devin Ceres Kelly on behalf of All Plaintiffs (Kelly, Devin) |
| Filing 19 NOTICE of Appearance by Roxanne Barton Conlin on behalf of Kristy Marken (Conlin, Roxanne) |
| Filing 18 NOTICE of Appearance by Richard A Stefani on behalf of CooperSurgical, Inc., Teva Pharmaceuticals USA Inc., Teva Women's Health, Inc., Teva Women's Health, LLC.(Individually and as successor in interest to Teva Women's Health, Inc. ), The Cooper Companies, Inc. (Stefani, Richard) |
| Filing 17 CLERK'S NOTICE TO ATTORNEYS/PRO SE PARTY: Your case has been opened in the SDIA and assigned a new case number. Please review the attached document and forms for compliance with this Court's Local Rules. Rule 16 Notice of Dismissal set for 2/15/2021. (kjw) |
| Filing 16 TEXT ORDER SETTING SCHEDULING CONFERENCE. A Telephonic Scheduling Conference set for 12/28/2020 at 10:00 AM before Chief Magistrate Judge Helen C. Adams. Counsel shall call 1-877-336-1829 and enter code 1176783. The parties shall file a proposed scheduling order and discovery plan as provided under L.R. 16 by 12/21/2020. Signed by Chief Magistrate Judge Helen C. Adams on 11/13/2020. (bam) |
| Filing 15 Case transferred in from District of Pennsylvania Eastern; Case Number 2:20-cv-05059. Original file certified copy of transfer order and docket sheet received. |
| Chief Judge John A. Jarvey and Chief Magistrate Judge Helen C. Adams added. (don) |
Filing 14
STIPULATION AND ORDER THAT THIS ACTION IS TRANSFERRED PURSUANT TO 28 U.S.C. 1404(a) TO UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF IOWA AS OUTLINED HEREIN. SIGNED BY HONORABLE HARVEY BARTLE, III ON 11/12/2020. 11/12/2020 ENTERED AND COPIES E-MAILED.(sg, )
|
| Filing 13 NOTICE of Appearance by RANDI KASSAN on behalf of KRISTY MARKEN (KASSAN, RANDI) |
| Filing 12 Original Record together with certified copy of docket entries received from Court of Common Pleas of PHILADELPHIA County. (JL ) |
| Filing 11 ANSWER to Complaint by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) |
| Filing 10 ANSWER to Complaint by THE COOPER COMPANIES, INC.(RUBENSTEIN, BRIAN) |
| Filing 9 ANSWER to Complaint by TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) |
| Filing 8 ANSWER to Complaint by TEVA WOMEN'S HEALTH INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) |
| Filing 7 ANSWER to Complaint by TEVA PHARMACEUTICALS USA, INC.(RUBENSTEIN, BRIAN) |
| Filing 6 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) |
| Filing 5 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA WOMEN'S HEALTH INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC..(RUBENSTEIN, BRIAN) |
| Filing 4 Disclosure Statement Form pursuant to FRCP 7.1 including TEVA PHARMACEUTICAL INDUSTRIES LTD. by TEVA PHARMACEUTICALS USA, INC.(RUBENSTEIN, BRIAN) |
| Filing 3 Disclosure Statement Form pursuant to FRCP 7.1 including THE COOPER COMPANIES, INC. by COOPERSURGICAL, INC..(RUBENSTEIN, BRIAN) |
| Filing 2 Disclosure Statement Form pursuant to FRCP 7.1 including VANGUARD GROUP, INC. by THE COOPER COMPANIES, INC.(RUBENSTEIN, BRIAN) |
| Filing 1 NOTICE OF REMOVAL by THE COOPER COMPANIES, INC, TEVA WOMEN'S HEALTH INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC., DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC., D/B/A TEVA WOMEN'S HEALTH, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC, TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC. (Filing fee $ 400 receipt number 0313-14632537), filed by THE COOPER COMPANIES, INC, TEVA WOMEN'S HEALTH INC., INDIVIDUALLY, AND AS SUCCESSOR IN INTEREST TO, DURAMED PHARMACEUTICALS, INC., A DIVISION OF BARR PHARMACEUTICALS, INC., DURAMED PHARMACEUTICALS, INC. A DIVISION OF BARR PHARMACEUTICALS, INC., D/B/A TEVA WOMEN'S HEALTH, INC., TEVA WOMEN'S HEALTH, LLC, INDIVIDUALLY AND AS SUCCESSOR IN INTEREST TO TEVA WOMEN'S HEALTH, INC., COOPERSURGICAL, INC., TEVA PHARMACEUTICALS USA, INC, TEVA WOMEN'S HEALTH, LLC f/k/a TEVA WOMEN'S HEALTH, INC..(RUBENSTEIN, BRIAN) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Iowa Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
